These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 33296098)
21. Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis. Liu D Cell Oncol (Dordr); 2019 Apr; 42(2):197-209. PubMed ID: 30645729 [TBL] [Abstract][Full Text] [Related]
22. Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression. Weng WH; Leung WH; Pang YJ; Hsu HH Oncol Rep; 2016 Jan; 35(1):107-16. PubMed ID: 26496897 [TBL] [Abstract][Full Text] [Related]
24. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer. Zou G; Wang R; Wang M Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664 [TBL] [Abstract][Full Text] [Related]
25. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer. Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182 [TBL] [Abstract][Full Text] [Related]
26. A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer. Day F; Muranyi A; Singh S; Shanmugam K; Williams D; Byrne D; Pham K; Palmieri M; Tie J; Grogan T; Gibbs P; Sieber O; Waring P; Desai J Target Oncol; 2015 Mar; 10(1):99-109. PubMed ID: 24859797 [TBL] [Abstract][Full Text] [Related]
27. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer. Shen X; Bai Y; Luo B; Zhou X Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study. Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286 [TBL] [Abstract][Full Text] [Related]
29. microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer. Takahashi H; Takahashi M; Ohnuma S; Unno M; Yoshino Y; Ouchi K; Takahashi S; Yamada Y; Shimodaira H; Ishioka C BMC Cancer; 2017 Nov; 17(1):723. PubMed ID: 29115941 [TBL] [Abstract][Full Text] [Related]
31. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis]. Wang Y; Yuan W; Ma X; Ma J Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461 [No Abstract] [Full Text] [Related]
32. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease. Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883 [TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability. Nazemalhosseini-Mojarad E; Kishani Farahani R; Mehrizi M; Baghaei K; Yaghoob Taleghani M; Golmohammadi M; Peyravian N; Ashtari S; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR J Gastrointest Cancer; 2020 Mar; 51(1):53-62. PubMed ID: 30635874 [TBL] [Abstract][Full Text] [Related]
34. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. Di Nicolantonio F; Martini M; Molinari F; Sartore-Bianchi A; Arena S; Saletti P; De Dosso S; Mazzucchelli L; Frattini M; Siena S; Bardelli A J Clin Oncol; 2008 Dec; 26(35):5705-12. PubMed ID: 19001320 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis. Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233 [TBL] [Abstract][Full Text] [Related]
36. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. Teng HW; Huang YC; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Wang HW; Chang SC; Lan YT; Lin CC; Wang HS; Yang SH J Surg Oncol; 2012 Aug; 106(2):123-9. PubMed ID: 22331825 [TBL] [Abstract][Full Text] [Related]
37. Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review. Dos Santos IL; Penna KGBD; Dos Santos Carneiro MA; Libera LSD; Ramos JEP; Saddi VA Mol Biol Rep; 2021 Feb; 48(2):1853-1867. PubMed ID: 33598796 [TBL] [Abstract][Full Text] [Related]
38. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer. Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940 [TBL] [Abstract][Full Text] [Related]
39. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer. Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284 [TBL] [Abstract][Full Text] [Related]
40. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Wang X; Wang J; Ma H; Zhang J; Zhou X Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]